1. Boston Consulting Group, 1993. The Contribution of Pharmaceutical Companies: What’s at Stake for America. The Boston Consulting Group, Boston, MA, September 1993.
2. US Congressional Budget Office, 1998. How Increased Competition from Generic Drugs has Affected Prices and Returns in the Pharmaceutical Industry. US Government Printing Office, Washington, DC, July 1998.
3. Clarkson, 1977. Intangible Capital and Rates of Return, American Enterprise Institute, Washington, DC.
4. CMR, 2000. Describing Dossiers: Characterising Clinical Dossiers for Global Registration. R&D Briefing 25, CMR International, Surrey, UK.
5. Cost of innovation in the pharmaceutical industry;DiMasi;Journal of Health Economics,1991